Source:http://linkedlifedata.com/resource/pubmed/id/18288441
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-3-12
|
pubmed:abstractText |
The effects of the non-peptide vasopressin V(2) receptor antagonist 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride (OPC-31260) on the cerebral oedema induced by general cerebral hypoxia were studied in rats. The general cerebral hypoxia was produced by bilateral common carotid ligation in Sprague-Dawley rats of the CFY strain. By 6 h after the ligation, half of the rats had died, but the survival rate was significantly higher following OPC-31260 administration. Electron microscopic examinations revealed typical ischaemic changes after the carotid ligation. The carotid ligation increased the brain contents of water and Na(+) and enhanced the plasma vasopressin level. The increased brain water and Na(+) accumulation was prevented by OPC-31260 administration, but the plasma vasopressin level was further enhanced by OPC-31260. These results demonstrate the important role of vasopressin in the development of the disturbances in brain water and electrolyte balance in response to general cerebral hypoxia. The carotid ligation-induced cerebral oedema was significantly reduced following oral OPC-31260 administration. The protective mechanism exerted by OPC-31260 stems from its influence on the renal vasopressin V(2) receptors. These observations might suggest an effective approach to the treatment of global hypoxia-induced cerebral oedema in humans.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzazepines,
http://linkedlifedata.com/resource/pubmed/chemical/OPC 31260,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Vasopressins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0942-0940
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
150
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
265-71
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:18288441-Animals,
pubmed-meshheading:18288441-Benzazepines,
pubmed-meshheading:18288441-Body Water,
pubmed-meshheading:18288441-Brain,
pubmed-meshheading:18288441-Brain Edema,
pubmed-meshheading:18288441-Brain Ischemia,
pubmed-meshheading:18288441-Disease Models, Animal,
pubmed-meshheading:18288441-Kidney,
pubmed-meshheading:18288441-Male,
pubmed-meshheading:18288441-Microscopy, Electron, Transmission,
pubmed-meshheading:18288441-Rats,
pubmed-meshheading:18288441-Receptors, Vasopressin,
pubmed-meshheading:18288441-Sodium,
pubmed-meshheading:18288441-Survival Rate,
pubmed-meshheading:18288441-Treatment Outcome,
pubmed-meshheading:18288441-Vasopressins,
pubmed-meshheading:18288441-Water-Electrolyte Balance
|
pubmed:year |
2008
|
pubmed:articleTitle |
Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
|
pubmed:affiliation |
Department of Comparative Physiology, University of Szeged, Szeged, Hungary.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|